| Literature DB >> 27698802 |
Junguo Wang1, Fang Mei2, Xia Gao1, Shoulin Wang3.
Abstract
Nasopharyngeal carcinoma (NPC) is the most common cancer originating from the nasopharynx, and can be induced by infection with Epstein-Barr virus (EBV). To study the mechanisms of EBV-associated NPC, a microarray of the GSE12452 dataset was analyzed. GSE12452 was downloaded from Gene Expression Omnibus and consisted of 31 NPC samples and 10 normal healthy nasopharyngeal tissue samples. The differentially-expressed genes (DEGs) were screened using the linear models for microarray data package in R. Using Database for Annotation, Visualization and Integrated Discovery software, potential functions of the DEGs were predicted by Gene Ontology and pathway enrichment analyses. With the information from the Search Tool for the Retrieval of Interacting Genes/Proteins database, the protein-protein interaction (PPI) network was visualized by Cytoscape. Furthermore, modules of the PPI network were searched using ClusterONE in Cytoscape. A total of 951 DEGs were screened in the NPC samples compared with the normal healthy nasopharyngeal tissue samples. Function enrichment indicated that the upregulated genes were associated with the cell cycle, cytoskeleton organization and DNA metabolism. Meanwhile, the downregulated genes were mainly associated with cell differentiation, hormone metabolism, inflammatory response and immune response. PPI networks for the DEGs suggested that upregulated mitotic arrest deficient 2-like 1 (MAD2L1; degree=133), proliferating cell nuclear antigen (PCNA; degree=125) and cyclin B1 (CCNB1; degree=115), and downregulated member A1 of aldehyde dehydrogenase 1 (ALDH1A1; degree=15) may be of great importance as they exhibited higher degrees on interaction. Mucin 1 (MUC1) was a key node of module 4. Overall, the study indicated that MAD2L1, CCNB1, PCNA, ALDH1A1 and MUC1 may have a correlation with EBV-associated NPC.Entities:
Keywords: Epstein-Barr virus; differentially-expressed genes; module analysis; nasopharyngeal carcinoma; protein-protein interaction network
Year: 2016 PMID: 27698802 PMCID: PMC5038861 DOI: 10.3892/ol.2016.4940
Source DB: PubMed Journal: Oncol Lett ISSN: 1792-1074 Impact factor: 2.967
Enriched GO functions and KEGG pathways for the upregulated and downregulated genes[a].
| A, Enriched GO functions for the upregulated genes | ||||||
|---|---|---|---|---|---|---|
| Category | Term | Description | Gene no. | Gene symbol[ | P-value | |
| BP | GO:0000279 | M phase | 53 | 5.27×10−30 | ||
| BP | GO:0022402 | Cell cycle process | 66 | 3.34×10−29 | ||
| BP | GO:0007017 | Microtubule-based process | 28 | 1.09×10−11 | ||
| BP | GO:0000226 | Microtubule cytoskeleton organization | 21 | 7.27×10−11 | ||
| BP | GO:0007346 | Regulation of mitotic cell cycle | 19 | 6.43×10−9 | ||
| BP | GO:0010564 | Regulation of cell cycle process | 13 | 7.79×10−6 | ||
| BP | GO:0006259 | DNA metabolic process | 41 | 1.80×10−12 | ||
| BP | GO:0006974 | Response to DNA damage stimulus | 28 | 5.83×10−8 | ||
| B, Enriched GO functions for the downregulated genes | ||||||
| Category | Term | Description | Gene no. | Gene symbol[ | P-value | |
| BP | GO:0030855 | Epithelial cell differentiation | 16 | 4.04×10−7 | ||
| BP | GO:0030216 | Keratinocyte differentiation | 7 | 3.48×10−3 | ||
| BP | GO:0010817 | Regulation of hormone levels | 12 | 5.75×10−4 | ||
| BP | GO:0034754 | Cellular hormone metabolic process | 5 | 4.25×10−2 | ||
| BP | GO:0002526 | Acute inflammatory response | 9 | 1.55×10−3 | ||
| BP | GO:0009611 | Response to wounding | 23 | 3.86×10−3 | ||
| BP | GO:0006959 | Humoral immune response | 8 | 1.89×10−3 | ||
| BP | GO:0002455 | Humoral immune response mediated by circulating immunoglobulin | 4 | 3.12×10−2 | ||
| C, Enriched KEGG pathways for the upregulated and downregulated genes | ||||||
| Regulation | Category | Term | Description | Gene no. | Gene symbol[ | P-value |
| Up | KEGG | 04110 | Cell cycle | 21 | 3.32×10−11 | |
| KEGG | 04512 | ECM-receptor interaction | 14 | 1.75×10−7 | ||
| KEGG | 03030 | DNA replication | 9 | 2.74×10−6 | ||
| KEGG | 03430 | Mismatch repair | 7 | 1.92×10−5 | ||
| KEGG | 04115 | p53 signaling pathway | 9 | 3.32×10−4 | ||
| Down | KEGG | 00980 | Metabolism of xenobiotics by cytochrome P450 | 8 | 1.82×10−4 | |
| KEGG | 00982 | Drug metabolism | 8 | 2.25×10−4 | ||
| KEGG | 00830 | Retinol metabolism | 6 | 4.45×10−3 | ||
| KEGG | 00590 | Arachidonic acid metabolism | 5 | 2.61×10−2 | ||
| KEGG | 04640 | Hematopoietic cell lineage | 6 | 2.96×10−2 | ||
The enriched GO terms listed in the table are the functions for the top four clusters with the highest enriched score.
Only the most relevant genes in each category are listed. GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; ECM, extracellular matrix; BP, biological process. KNTC, kinetochore associated; KIF, kinesin family; CAV, caveolin; CDK, cyclin-dependent kinase; CDC, cell division cycle; DLGAP, discs large homolog associated protein; TIPIN timeless-interacting protein; UNG, uracil DNA glycosylase; PRKDC, protein kinase, DNA-activated, catalytic polypeptide; SPRR, small proline rich protein; PPL, periplakin; CNFN, cornifelin; DHRS, dehydrogenase/reductase (SDR family); UGT, UDP glucuronosyltransferase; ELF3, E74-like ETS transcription factor 3; FOX, forkhead box; ANX, annexin; FAM, family with sequence similarity; DUOX, dual oxidase; F3, coagulation factor III, tissue factor; CLU, clusterin; SAA4, serum amyloid A4, constitutive; S100A9, S100 calcium binding protein A9; PRDX, peroxiredoxin; CFB, complement factor B; C7, complement component 7; CD, cluster of differentiation; CR2, complement component 3d receptor 2; COL, collagen; RFC, replication factor C; DNA2, DNA replication helicase/nuclease 2; EXO, exonuclease; MSH, mutS homolog; CCN, cyclin; GSTA, glutathione S-transferase alpha; ADH, alcohol dehydrogenase; AKR, aldo-keto reductase; GGT, gamma-glutamyltransferase; ALOX15, arachidonate 15-lipoxygenase; MS4A1, membrane spanning 4-domains A1.
Figure 1.Module 1 obtained from the protein-protein interaction network of upregulated genes.
Figure 2.Module 2 obtained from the protein-protein interaction network of upregulated genes.
Figure 3.Module 3 obtained from the protein-protein interaction network of downregulated genes.
Figure 4.Module 4 obtained from the protein-protein interaction network of downregulated genes.